Process Development

Process Development
Product Description

The clinical and commercial success of biotherapeutics hinges on developing robust, reproducible, and scalable processes. KBI's extensive process development and analytical development capabilities help our partners generate active products at an attractive cost while enabling rapid, reliable transfer to cGMP manufacturing.

KBI's process development activities cover the full development cycle. We support early-stage discovery efforts through small-scale protein production to fully-integrated, comprehensive process development programs leading to cGMP manufacturing to process characterization and scale-down validation studies. We take pride in our deep knowledge and experience in the science and practice of biopharmaceutical drug development. Our abiding customer focus and situational flexibility combined with a solid scientific base enable us to be the ideal partner for our clients' biopharmaceutical process development needs.

KBI Biopharma Inc.

  • US
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Contract Manufacturer
Specifications
  • Details
    Supporting Process Development for both Mammalian and Microbial Expression Systems
  • Model
    https://www.kbibiopharma.com/capabilities/services/fermentation-process-analytical-development
  • Supplied from
    Switzerland; United States
  • Measured In
    piece

KBI Biopharma Inc.

  • US
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Contract Manufacturer

More Products from KBI Biopharma Inc. (14)

  • PUREplatform™

    Product PUREplatform™

    At KBI Biopharma, our PUREplatform is everything you need to make a protein. Containing plasmids, strains, media, and a fermentation process that all fit together into a service package catered to your needs. 

    • Features our PUREcoli™ cell line, our proprietary high-producing E. coli ce...
  • SUREmAb™

    Product SUREmAb™

    Built on the SUREtechnology Platform, SUREmAb optimizes monoclonal antibody (mAb) development and manufacturing processes, fast-tracking the path to clinic and market. • Fast-tracked for efficiency and speed, taking you from DNA transfection to GMP drug substance in 11 months • Comprehensive mAb develop...
  • SUREtechnology Platform™

    Product SUREtechnology Platform™

    With our advanced gene technology and proprietary cell line, we are able to overcome common bottlenecks that come with developing high-performance mammalian cell lines, especially when expressing novel molecule types.

    Mammalian cells are the gold standard for biologics development. 

    ...
  • Biologic Drug Substance & Drug Product Formulation

    Product Biologic Drug Substance & Drug Product Formulation

    To date, KBI has conducted over 130 successful protein, peptide, and vaccine formulation development programs. KBI's approach to formulation development is based on the strategic pairing of two complementary scientific disciplines: Establishing a comprehensive understanding of the thermal, physical, chemic...
  • cGMP Protein and Antibody Purification

    Product cGMP Protein and Antibody Purification

    KBI Biopharma has extensive experience developing purification processes for a wide variety of biotherapeutics, including: -Monoclonal antibodies-Bispecific antibodies -Enzymes -Fc fusion proteins -PEGylated proteins -Complex glycoproteins KBI supports 40+ annual programs ranging from FIH (First-in-Huma...
  • Cell Line Development

    Product Cell Line Development

    KBI offers a full suite of CLD across both mammalian and microbial expression systems. KBI can apply established mammalian recombinant protein expression systems to provide rapid and industry-leading cell line generation services using: CHO-M Selexis SUREtechnology, CHO-ZN, CHO-DG44, CHO-S, and CHO-K1 GS. ...
  • Analytical Development

    Product Analytical Development

    With top expertise in protein analytics, KBI has successfully completed over 3300 analytical projects for more than 300 customers and more than 130 distinct molecules.


    Our experience includes antibodies (IgG1, IgG4, IgM, FAb, ADC, Fc fusion), enzymes, cytokines, growth factors, highly glycosylat...
  • Formulation Development

    Product Formulation Development

    KBI’s approach to formulation development is based on the strategic pairing of two complementary scientific disciplines:
    • Establishing a comprehensive understanding of the thermal, physical, chemical, and conformational stability. • Employing statistical design-of-experiment (DOE) to evaluate main ef...
  • Characterization

    Product Characterization

    Scale-down process characterization studies performed using a qualified scale-down model are a critical part of licensure applications for biologics. 

    KBI has significant expertise in the design and execution of these studies to enable customers to define their process control strategy to take ...
  • Clinical Manufacturing

    Product Clinical Manufacturing

    KBI Biopharma offers a broad range of cGMP biologics manufacturing services to biopharmaceutical companies worldwide. Our capabilities include reliable manufacturing for preclinical and clinical supply.

    KBI’s experienced team produces high-quality therapeutics and vaccines thro...
  • cGMP Mammalian Production

    Product cGMP Mammalian Production

    KBI offers global cGMP Mammalian Production, and organizational highlights include:  • First CDMO to implement 2,000L single-use cGMP operations • High throughput single-use technology (AKTA Ready XL, 2500L SUM, 12m2 TFF) • A broad range of cGMP biologics manufacturing services from pre-clinical thr...
  • cGMP Microbial Production

    Product cGMP Microbial Production

    The KBI Boulder facility has extensive experience in generating E. coli based expression systems for high-level expression of recombinant proteins, typically using T7 expression in the BL21(DE3) strain as a platform. Following demonstration of expression in shake flasks, fermentation development ...

KBI Biopharma Inc. resources (26)

  • News CPHI Barcelona 2023: Tackling the Pharma Talent Precipice – Part 2

    This year at CPHI Barcelona (24–26 October, 2023) we sat down with C-suite executives and HR professionals to discuss the looming talent crisis in the pharmaceutical industry. With hybrid working persisting post-pandemic and a growing skills gap, how can the pharmaceutical supply chain adjust to a changing labour force? 
  • Whitepaper Navigating a New Standard in Microbial Protein Expression

    An ideal therapeutic protein “factory” creates a pure target product with high titers from the start, which can minimize development risk, timelines, and cost. E. coli has long been implemented as a therapeutic protein factory due to its simplicity, tractability, and wealth of information characterizing the microbe.

    While common E. coli expression strains alter as many as five genes to improve one aspect of recombinant protein expression, KBI has created a platform E. coli with about 1,000 genes altered and roughly 1 Mbp of DNA removed. The result is a PURE, efficient platform expression strain—PUREcoli™.

  • News Aaron Pilling Discusses the KBI PUREplatform Launch

    KBI's PUREplatform™  is a game-changing microbial expression offering that redefines biopharmaceutical manufacturing.

    Hear from Aaron Pilling, Ph.D., Senior Director of Process Development, as he discusses the KBI PUREplatform, a premium microbial CLD platform that delivers unmatched efficiencies. 
  • Video Titration Curve Modeling in Bioassay Potency Method Development

    In the contract laboratory environment, the time constraint is ever-present and works against both the contract lab and the client or sponsor. This is especially true for the cell-based potency testing teams, where the assays have an infinite number of variables ranging from optimal growth conditions to the generation of the ideal titration curve to accurately measure any effect on the targeted mechanism of action. To overcome this ever-present hurdle, the Cell-Based Assay Team at KBI utilizes a titration curve modeling tool to effectively predict the cellular response to an agonist or antagonist.
  • News Executive Team - About KBI & Selexis Operational Consolidation

    Hear from our parent company JSR Life Sciences and our executive team about the operational consolidation of KBI and Selexis as one organization. Get their perspective on how this brings us one step further on the path of becoming the icon of next-generation CDMOs and how the benefits translates for our partners.
  • Webinar BsAbs purification with affinity capture and mix-mode chromatography

    Watch the webinar to see how KBI Biopharma and JSR Life Sciences have developed processes for the purification of bispecific antibodies using Amsphere™ A3 affinity chromatography followed by two polishing steps to eliminate undesirable homodimers and other impurities.
    In this webinar, we discuss bispecifics purification, including:- Challenges of bispecifics purification
    - Protein A affinity capture chromatography design
    - Comparison of Protein A resin and alternative affinity capture resin for bispecifics
    - Mixed-mode Chromatography design for bispecifics
  • News KBI Strengthens Leadership With Executive Appointments

    KBI announces four recent executive appointments to continue its momentum and vision of becoming a next-generation CDMO. Joining the company are Tony Fraij, COO; Shaguna Seth, Chief of Staff and Global PMO Leader; Katie Edgar, SVP of Corporate Strategy and Alliance Management; and Sarah Wakefield, SVP, Corporate Communications.
  • Whitepaper Delivering on the Promise of Bispecifics: Antibody Development

    A breakthrough approach to bispecific production via streamlined workflow; cell line development to GMP manufacturing.
  • News Unveiling KBI PUREplatform™, a Game-Changing Microbial Offering

    KBI announced the launch of KBI PUREplatform™, a premium microbial cell line development platform that features unmatched efficiencies for biopharmaceutical production. A culmination of decades of expertise, the platform addresses challenges, empowering customers to bring products to market cheaper and easier.
  • Webinar Streamlined Development and Production of Bispecific Antibodies

    There is a global need for high quality, effective off-the-shelf therapies that can be used immediately, while concurrently avoiding supply chain issues and mitigating process complexities. Bispecific antibodies (bsAbs) are constructed to help meet this need due to their ability to bind to two or more different epitopes, thereby allowing them to perform multiple discrete mechanisms of action.

    This webinar will demonstrate a breakthrough platform approach that encompasses the efficient production of bispecific molecules in an integrated, streamlined way, from CLD (cell line development) to cGMP manufacturing. The leverageable integrated workflow from KBI Biopharma and Selexis generates high quality clinical bulk drug substances under accelerated timelines.

  • News KBI Appoints Marykay Marchigiani CFO and Sigma Mostafa, Ph.D., CSO

    Durham, North Carolina (May 10, 2023)  – KBI, a JSR Life Sciences company, today announced the appointment of Marykay Marchigiani as Chief Financial Officer and Sigma Mostafa, Ph.D., as Chief Scientific Officer. The additions will allow KBI to fulfill its growth strategy of becoming a next-generation CDMO.
  • Webinar Development of Protein A Continuous Chromatography

    In this Webinar, KBI Biopharma, in collaboration with JSR Life Sciences, introduces a hybrid approach to multicolumn continuous chromatography (MCC) that converts the Protein A (ProA) capture chromatography step to a continuous chromatography process, offering many of the advantages of the MCC process while avoiding the challenges associated with connecting process steps.

    Rapid advances in intensifying upstream processes for biologics production to achieve higher titers have left downstream processing as a potential bottleneck in the manufacturing scheme. MCC is an emerging technology that can significantly reduce material costs and time in plant. This mode of chromatography can lead to shorter processing times and improve efficiency as well as productivity compared to a traditional batch process.

    Here, we focus on the conversion of a batch ProA step using Amsphere A3 resin to a 4-column continuous process on a BioSMB system.
  • News KBI Appoints David Stewart Site Head of Durham cGMP Facility

    Stewart has more than two decades of biotech leadership experience and a proven record of delivering best-in-class supply for patients. He will oversee all operations at Patriot Park, Durham, North Carolina, driving deliverables for KBI’s global biopharmaceutical customers.

  • Brochure KBI Biopharma Extends Commercial Contract with Leading Pharmaceutical Co.

    KBI Biopharma announced that it has extended and expanded its manufacturing contract with a leading global pharmaceutical company.
  • News KBI Geneva Inaugural FIH Batch Released Five Months After Opening

    In late 2022, KBI successfully released its inaugural FIH manufacturing batch in compliance with cGMP standards in its recently expanded Geneva mammalian cell manufacturing facility. This important milestone demonstrates the capabilities of KBI, allowing clients to accelerate clinical research timelines.
  • Brochure KBI Biopharma Recognized as a Leader in Six Categories

    KBI Biopharma Recognized as a Leader in All Six Categories of the 2024 CDMO Leadership Awards
  • News KBI Biopharma Announced as 2023 ISPE Facility Finalist

    KBI Biopharma is thrilled to announce that its Patriot Park facility has been named a finalist in the 2023 ISPE Facility Of The Year Aawards (FOYA) in two categories: operations and pharma 4.0
  • Brochure KBI Biopharma and Argonaut Manufacturing Forge Strategic Alliance

    KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies
  • News Subcontract with Mapp on Sudan ebolavirus Treatment

    Following the recent Sudan ebolavirus outbreak in Uganda, KBI is providing emergency support through global production efforts.KBI announced it entered into a subcontract with Mapp for the continued development and manufacturing of MBP134, an experimental combination monoclonal antibody treatment for Sudan ebolavirus.
  • Brochure KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

    Jean-Baptist Joins the KBI Biopharma Team as Chief Business Officer
  • News KBI Biopharma and Selexis SA Appoint J.D. Mowery as CEO

    KBI Biopharma and Selexis, announced in April 2023 the appointment of J.D. Mowery as CEO. Widely respected as an innovative biotech leader with a nearly 25-year track record of successfully inspiring colleagues and building organizations, J.D. will lead KBI and Selexis into becoming a leader in the next CDMO generation.
  • Brochure SUREmAb™ - mAb Development, The Way It's Meant to Be

    Innovative approach to monoclonal antibody development. Powered by Selexis®.
  • News Streamlined Development for Efficient Production of Bispecific Molecules: Connect to Frankfurt on-demand

    In this Connect to Frankfurt session, Séverine Fagète, VP, Cell Line Development Services at Selexis (Geneva, Switzerland), and Brandon Brino (Durham, USA), Process Development Scientist and Group Leader at KBI Biopharma, present an overview of a streamlined process for the production of bispecific molecules.  
  • Brochure PUREplatform™ - Breakthrough Approach to Microbial Expression

    Titers up to 50 g/L empowering cost-effective biomanufacturing
  • News KBI Biopharma and Selexis to Operate as one Organization

    KBI Biopharma and Selexis are consolidating as one organization to accelerate innovation and growth for global biopharma customers. The new structure will enable integrated, seamless solutions, from cell line development through process development, to clinical and commercial cGMP manufacturing for mammalian programs.
  • Video Rapid Timeline to Tox Starting with KBI Biopharma's SUREtechnology Platform™, Powered by Selexis

    KBI Biopharma’s cell line development services, powered by Selexis®, have been at the forefront of innovation for the last two decades. We are introducing the latest version of proprietary SURE CHO-M technology, which uses a transposase-based semi-targeted integration method and provides high productivity and stable cell lines for therapeutic protein production, while exhibiting a doubling time of 15-17 hours. Using this transposase-based cell line, KBI Biopharma is now delivering tox material in as little as 6 months from transfection. The tox material will be generated with the top 6 clones. In addition, we are introducing an afucosylated host cell line for the generation of therapeutic proteins without any fucose residues. KBI Biopharma is also introducing a completely new targeted integration technology developed by our own next-generation sequencing software. This panel of new cell line offerings surpasses customer expectations and is set to establish new industry standards.

Frequently Viewed Together

  • Product Process Development & Inhaled Product Manufacturing

    In addition to extensive development manufacturing facilities, Vectura has GMP manufacturing facilities for dry powder inhalers, pMDI and nebuliser medical devices as well as further capability to handle biological molecules. 

    Our GMP manufacturing facilities and equipment are relevant-to-comme...
  • Product Ibuprofen Pellets (IBU DC100)

    Your benefits
    - 100 % Ibuprofen in pellet form, without any additive
    - wide range of pellets sizes to cover various applications
    - produced according to GMP guidelines
    - reduce punch wastage and sticking problems due to very spherical shape
    - full ...
  • Product API & INTERMEDIATES

    The CDMO Division of KD Pharma excels in the production of drug intermediates and API drug substances. We offer our customers the full spectrum of drug services: • R&D development material for preclinical studies       • Pilot plant for phase I, II and III supplies • Large scale p...
  • Product Auxiliar y Servicios DELSAZ

    Auxser is the leader in maintenance and optimization of lyophilization processes. With more than 15 years of experience working with the main pharmaceutical and food companies, Auxser has a team of professionals and specialized media in the maintenance, repair and optimization of lyophilizers in Spa...
  • Product A.I. Innovation for Visual Inspection

    From standard vision systems for blister filling or label application, up to automatic visual inspection machines, artificial intelligence can boost quality control performance as well as empower the advanced optimization of maintenance activities – including predictive a...
  • Product Development of chemo-enzymatic processes

    Inspired by solutions found in biological systems, we are proficient in developing robust chemo-enzymatic processes to produce your target compound. A strong platform on biocatalytic transformations and the ability to develop novel bio-inspired synthesis strategies for your product are our unique selli...
  • Product Automated NIR Spectroscopy

    The SPECTRA NIV is a high speed inspection platform for the non-destructive acquisition and analysis of NIR spectra of lyophilized products. NIR spectroscopy allows the determination of multiple parameters simultaneously such as moisture concentration, defects of the lyophilizate and the identification of ...
  • Product Process Development

    BioDuro-Sundia's process development services support drug substance production,  providing an efficient path to manufacture API or intermediates. Our extensive services support production of API for GLP toxicology studies, IND-enabling studies, clinical studies, and commercialization efforts. qq...
  • Product Process development

    Rommelag CMO provides wide range of services which includes process development. It offers production of pilot batches for process development, filtration tests for sterile filtration, scale-up experiments, microbiological tests (internally or in cooperation with external microbiology laboratories), compre...
  • Product The Competence circle of Biazzi

    BIAZZI supplies a complete know-how and engineering package as well as the related process equipment. BIAZZI offers tests in its test centre to upscale processes and make the basis for the design of the industrial plant. Biazzi is offering the delivery of the Key-Equipment/Basic Engineering or full SKID mo...
  • Product Formulation and process development

    Do you have an NCE that needs to be formulated in a solid dosage form or having challenging process and formulation questions, then XEDEV is your partner to assist you, as we are specialised in formulation and process development through drying, granulation, tableting and/or coating processes.

    P...
  • Product Complete Second-hand Process Plants

    IPP owns over 100 complete plants across the globe and with our vast customer relationships, we have the knowledge of hundreds more available or purchase to be operated in place or readily available to be dismantled and shipped to your preferred location. Save 70% of the cost of the equipment a...
  • Product GMP small parts cleaning systems

    GMP-compliant cleaning of small parts, containers, plant parts, hoses, separator parts and much more. Highlights: 1 Vertical opening sliding door made of safety glass 2 Electropolished cleaning chamber with rounded corners 3 Visual and audible signal light 4 12" Siemens Touch Panel 5 Hygienic design contr...
  • Product Pre-assemble processing skids

    Briggs design and manufacture pre-assembled processing skid units. We have examples where Briggs have supported lab scale trails to pilot trails which have then enabled the design and manufacture of manufacturing scale units.Our skids are usually bespoke design and Briggs offer a turnkey package which can ...
  • Product Industrial Vacuum Cleaners

    RGS offers a wide range of industrial vacuum cleaners of various powers and capacity: industrial vacuum single-phase, three-phase, flameproof and with compressed air. There are also specific models for oils and chips, others for applications in the food and pharmaceutical industries as ...
  • Product Scale up simulation and optimization

    We provide scale up and optimization strategy. Scale up is based on experimental small scale data (by Designed experiments) and fed into our simulation system.We use physics and chemistry based modeling in our simulations (no black boxing).
    Get the digital twin of your process!
    Results are clear cont...
  • Product Print Inspection ManageArtworks

    Detect printing errors before they hit the market ! While print technology has improved over the years, it's the responsibility of the brand to make sure the packaging and labeling that is released to the market is correct in all respects. The onus of checking that the quality of the labeling is corre...
  • Product Clean / Pure steam humidifier Condair SETC

    Humidity Technologies offers a steam generator to generate a clean/pure steam at atmospheric pressure for humidification purpose. In most phramaceutical manufacturing plants - especially OSD facilities pure steam is not available. However boiler steam is available but it is not advisable to use this steam ...
  • Product Eyecon2

    Direct Imaging Particle Analyser for real time in-line and at-line use on solids processing equipment
  • Product Asset Performance Monitoring - Software Solution

    Manufacturing Performance Monitoring Suit - A Prebuild, Plug & Play Solution that Fully addresses, all your KPIs to make Manufacturing Processes Lean, Shop Floor managers more Insightful, Efficient, Accountable and Connected with revenue in Real time. MPM will enlighten you with .
    ...
  • Product Clinical Supply Manufacturing

    NCEs • Phase I-III formulation process development and clinical supply manufacturing Generic drugs
    • BE sample manufacturing • Process Optimization
  • Product Clinical Trial Material Manufacturing

    PMI Bio provides product development services and cGMP manufacturing for Phase I and Phase II clinical trials. Key capabilities include process development, non-sterile manufacturing and filling of liquids and creams, aseptic filling and finishing and the ability to provide microfluidization of liquids an...
  • Product GEA Pharma & Healthcare

    Why GEA?

    We supply the added value and the deep-rooted knowledge that counts.

    We can support your process or provide the inspiration you need to meet your objectives.

    GEA has developed a deep and thorough understanding of the challenges you face, the hurdles you need to ove...
  • Product Biocatalytic R&D servcies

    Enzyme screening and R&D services
    Enzyme custom development and enzyme manufacturing
    Routescouting, enzyme discovery and improvement Bulk enzyme supplier

  • Product CMO/CDMO Services

    - State of the Art GMP approved Biotech and Sterile Drug Product Facilities

    - Pilot Scale Facility and Scale Up/Scale Down Model- QC Laboratory Capability and Lab Services- Available Capacity and customized CDMO/Solutions

    - On-Site Facilities Available for start-up Biotech/Pharma co...
  • Product NG Feeder

    TEG Provide a free consultation service; Recommendation of the best feeder for your project. Test tubes/tracks and 3D simulations can also be supported. Onsite test rigs that can accommodate all feeders for testing intermittently or continuous, depending on the end users requirements. Offe...
  • Product Biologic Drug Substance & Drug Product Formulation

    To date, KBI has conducted over 130 successful protein, peptide, and vaccine formulation development programs. KBI's approach to formulation development is based on the strategic pairing of two complementary scientific disciplines: Establishing a comprehensive understanding of the thermal, physical, chemic...
  • Product Seat valves

    Seat valves are the extremely reliable all-rounders in the valve world. Our range includes on/off and control valves in stainless steel or bronze, with a stainless steel bonnet or a lightweight plastic actuator. They are available with a threaded or Tri-clamp connection, actuation is either pneu...
  • Product Spray-drying

    Spray-drying is an instant and continuous solvent evaporation process of a liquid feed, atomised in a heated gas, generating a final dried solidified particle.The heated drying gas moves in co-flow with the atomised feed in the process chamber where the gas transfers its heat energy to the droplets and abs...
  • Product Blending systems

    In pharmaceutical processes, but also in the food industry, very high demands are placed on the blending of products and raw materials. Uniform mixing or homogenisation is indispensable for further processing and the quality of the product. We offer various systems that blend your powders and granules safe...
  • Product Material Handling

    MBL offers the necessary equipment to meet the requirements of the biotech, fine chemicals and pharmaceutical industries: From IBCs/containers and drums to conveyor technology for horizontal or vertical material transport. For every task, you will find a solution for your process at MBL. Containers/IBCs: ...
  • Product Lifting Systems

    To meet intralogistics requirements within production processes as well as handling tasks during actual production, we offer a wide range of lifting systems. Our lifting systems are characterised by their ease of use and pharmaceutical-grade design. When particularly high loads have to be handled, our sta...
  • Product Sterile-valves

    In many industries, purity commands top priority. Sterile valves from Schubert & Salzer operate to the highest requirements for purity with maximum efficiency: The bodies are CIP and SIP capable, to avoid contamination by bacteria. In addition, these aseptic valves have no dead spaces. Right...
  • Product cGMP Protein and Antibody Purification

    KBI Biopharma has extensive experience developing purification processes for a wide variety of biotherapeutics, including: -Monoclonal antibodies-Bispecific antibodies -Enzymes -Fc fusion proteins -PEGylated proteins -Complex glycoproteins KBI supports 40+ annual programs ranging from FIH (First-in-Huma...
  • Product Scale-up Process Guarantees

    BIAZZI scales up laboratory hydrogenation results (1 liter)  directly to any size of industrial plants up to 60'000 ltr and gives performance guarantees covering capacity, product yield & quality, and catalyst consumption. Based on the tests results the industrial plant is designed and built in ...
  • Product Cell Line Development

    KBI offers a full suite of CLD across both mammalian and microbial expression systems. KBI can apply established mammalian recombinant protein expression systems to provide rapid and industry-leading cell line generation services using: CHO-M Selexis SUREtechnology, CHO-ZN, CHO-DG44, CHO-S, and CHO-K1 GS. ...
  • Product GMP container cleaning systems

    GMP-compliant cleaning for the pharmaceutical, fine chemical and life science industries: Clean containers, drums or other goods. As a combined washing and drying system or as a two-chamber system with separate washing and drying chambers. You get a consistently good, validated cleaning result. Highlights ...
  • Product cGMP Mammalian Production

    KBI offers global cGMP Mammalian Production, and organizational highlights include:  • First CDMO to implement 2,000L single-use cGMP operations • High throughput single-use technology (AKTA Ready XL, 2500L SUM, 12m2 TFF) • A broad range of cGMP biologics manufacturing services from pre-clinical thr...
  • Product Analytical Development

    With top expertise in protein analytics, KBI has successfully completed over 3300 analytical projects for more than 300 customers and more than 130 distinct molecules.


    Our experience includes antibodies (IgG1, IgG4, IgM, FAb, ADC, Fc fusion), enzymes, cytokines, growth factors, highly glycosylat...
  • Product Characterization

    Scale-down process characterization studies performed using a qualified scale-down model are a critical part of licensure applications for biologics. 

    KBI has significant expertise in the design and execution of these studies to enable customers to define their process control strategy to take ...
  • Product Core Technologies and Services

    • API / GMP Manufacturing • Rapid Process Development, Flawless Upscaling, and Economy of Scale-Production  • Simulated-Moving Bed (SMB) Chromatography  • Heterocyclic, Hazardous and Malodorous Chemistries • Organometallic and Cryogenic Chemistry • Transition-Metal Catalysis • High-Pressur...
  • Product Formulation Development

    KBI's approach to formulation development is based on the strategic pairing of two complementary scientific disciplines:
    • Establishing a comprehensive understanding of the thermal, physical, chemical, and conformational stability. • Employing statistical design-of-experiment (DOE) to evaluate main ef...
  • Product Sliding-Gate Valves

    This is how easy control can be. Over 30 years ago, Schubert & Salzer Control Systems took a new approach in control valves. We developed the sliding gate control valve: a handy, light and highly accurate valve. It operates based on a principle that had already excited Leonardo Da Vinci. Even ...
  • Product Dust Collectors

    RGS designs and manufactures continuous duty maintenance free dust and fume extraction systems for single and multiple points of extraction. The units with smaller footprint are available from 0.3 Kw to 7.5 Kw and high power units can be used for multiple and centralized extraction. Our...
  • Product Clinical Manufacturing

    KBI Biopharma offers a broad range of cGMP biologics manufacturing services to biopharmaceutical companies worldwide. Our capabilities include reliable manufacturing for preclinical and clinical supply.

    KBI's experienced team produces high-quality therapeutics and vaccines thro...
  • Product Intensified Synthesis

    As a service provider, Secoya develops new synthesis processes mostly based on flow chemistry. By downscaling reactor size, an optimal control of the process is achieved, enabling production of products with very high quality attributes. Secoya has a robust expertise in this field and has developed a metho...
  • Product Development Sciences

    Our development laboratories are well equipped for conducting a diverse range of experiments. These encompass formulation development, cycle design and process refinement, as well as evaluating finished product. Ease of scale-up is accomplished by completing process development studies within a pilot scale...
  • Product Quality - QEdge - Enterprise Quality Management Suite

    Sarjen Systems' QEdge is an enterprise-wide Quality Management System (QMS) specifically designed for pharmaceutical manufacturing. This risk-based QMS offers a comprehensive suite of solutions, including:
    • Process Control • Document Control & Issuance • Training Management System • Ve...
  • Product Development & Manufacturing by Contract

    IntelGenx offers full service to foster the growth of its partners. Our State-of-the-art facilities are equipped with the most modem equipment to deliver high-quality, cost-effective film products, while accommodating client requirements at each stage of product development. Int...
  • Product SIMULATED MOVING BED CHROMATOGRAPHY (SMB)

    KD Pharma is a contract manufacturer that develops products in the pharmaceutical space by employing state-of-the-art technology. Since its inception in 1988, KD Pharma has focused on utilizing cutting edge technologies to develop and manufacture exceptional quality APIs. These twin pillars of technology a...